Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Diabetes Research and Clinical Practice|February 26, 2018
Use of parenteral glucocorticoids and the risk of new onset type 2 diabetes mellitus: A case-control studyAla Keyany, Johannes T H Nielen, Patrick C Souverein, et al.Diabetes Research and Clinical Practice|January 28, 2019
Impact of the definition of osteoarthritis and of the timing of its onset on the association between type 2 diabetes mellitus and osteoarthritis: Clinical Practice Research DatalinkJohannes T H Nielen, Pieter C Dagnelie, Annelies Boonen, et al.British Journal of Clinical Pharmacology|April 30, 2015
Measuring anticholinergic drug exposure in older community-dwelling Australian men: a comparison of four different measuresLisa G Pont, Johannes T H Nielen, Andrew J McLachlan, et al.Diabetes, Obesity & Metabolism|July 2, 2024
Incretin-based therapy and the risk of diabetic foot ulcers and related eventsNikki C C Werkman, Johanna H M Driessen, Olaf H Klungel, et al.Medicine|May 20, 2016
Severity of Diabetes Mellitus and Total Hip or Knee Replacement: A Population-Based Case-Control StudyJohannes T H Nielen, Pieter J Emans, Pieter C Dagnelie, et al.British Journal of Clinical Pharmacology|September 17, 2015
Use of thiazolidinediones and the risk of elective hip or knee replacement: a population based case-control studyJohannes T H Nielen, Frank de Vries, Pieter C Dagnelie, et al.Cardiovascular Diabetology|June 29, 2023
The use of sodium-glucose co-transporter-2 inhibitors or glucagon-like peptide-1 receptor agonists versus sulfonylureas and the risk of lower limb amputations: a nation-wide cohort studyNikki C C Werkman, Johanna H M Driessen, Coen D A Stehouwer, et al.Pharmacoepidemiology and Drug Safety|September 6, 2016
Safety and efficacy of new oral anticoagulants and low-molecular-weight heparins compared with aspirin in patients undergoing total knee and hip replacementsJohannes T H Nielen, Pieter C Dagnelie, Pieter J Emans, et al.Current Drug Safety|August 10, 2020
Use of Sodium-Glucose Co-Transporter-2-Inhibitors (SGLT2-Is) and Risk of Lower Limb AmputationNikki C C Werkman, Johannes T H Nielen, Joop P W van den Bergh, et al.Diabetic Medicine : a Journal of the British Diabetic Association|October 17, 2021
Incidence, hospitalization and mortality and their changes over time in people with a first ever diabetic foot ulcerJohan Røikjer, Nikki C C Werkman, Niels Ejskjaer, et al.Pageof 2